CATHERINE DANFORD: Open Payments
NPI 1356806038 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,859 in 130 payments from 26 companies in 2025. Trend: 2023 $938 · 2024 $2,335 · 2025 $2,859
Food & beverage: $2,859
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 25 | $416 |
| UCB, Inc. | 13 | $337 |
| ABBVIE INC. | 13 | $323 |
| Novartis Pharmaceuticals Corporation | 13 | $252 |
| AstraZeneca Pharmaceuticals LP | 7 | $239 |
| Janssen Biotech, Inc. | 14 | $218 |
| ANI Pharmaceuticals, Inc. | 8 | $151 |
| E.R. Squibb & Sons, L.L.C. | 5 | $129 |
| GlaxoSmithKline, LLC. | 4 | $103 |
| Radius Health, Inc. | 3 | $82 |
Products named: Bimzelx, COSENTYX, SAPHNELO, TREMFYA, PURIFIED CORTROPHIN GEL, RINVOQ, ORENCIA, OTEZLA.
Industry payments across NC — which companies pay providers there.
